| A Randolph Pearlstein Md A Medical Corporation | |
|
9400 Brighton Way Suite# 201 Beverly Hills CA 90210-4712 | |
| (310) 271-6229 | |
| (310) 271-9137 |
| Full Name | A Randolph Pearlstein Md A Medical Corporation |
|---|---|
| Speciality | Internal Medicine |
| Location | 9400 Brighton Way, Beverly Hills, California |
| Authorized Official Name and Position | Alec Randolph Pearlstein (PRESIDENT) |
| Authorized Official Contact | 3102716229 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| A Randolph Pearlstein Md A Medical Corporation 9400 Brighton Way Suite# 201 Beverly Hills CA 90210-4712 Ph: (310) 271-6229 | A Randolph Pearlstein Md A Medical Corporation 9400 Brighton Way Suite# 201 Beverly Hills CA 90210-4712 Ph: (310) 271-6229 |
| NPI Number | 1063600443 |
|---|---|
| Provider Enumeration Date | 10/10/2007 |
| Last Update Date | 04/22/2020 |
| Medicare PECOS PAC ID | 4688823412 |
|---|---|
| Medicare Enrollment ID | O20121011000055 |
News Archive
Research presented at the ASM Microbe research meeting provides compelling evidence that children acquire Streptococcus mutans, the bacterium most frequently associated with dental caries, from intra- and extra-familial sources besides their mother.
Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.
Freescale Semiconductor today announced the newest addition to its growing Kinetis 32-bit microcontroller (MCU) line - the Kinetis K50 family. This new family, targeted for medical and industrial applications, further expands the industry's most extensive and scalable portfolio built on the ARM® Cortex™-M4 core.
Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063600443 | NPI | - | NPPES |
| 00G273080 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Alec R Pearlstein |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134268501 PECOS PAC ID: 8123211307 Enrollment ID: I20101020000631 |
News Archive
Research presented at the ASM Microbe research meeting provides compelling evidence that children acquire Streptococcus mutans, the bacterium most frequently associated with dental caries, from intra- and extra-familial sources besides their mother.
Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.
Freescale Semiconductor today announced the newest addition to its growing Kinetis 32-bit microcontroller (MCU) line - the Kinetis K50 family. This new family, targeted for medical and industrial applications, further expands the industry's most extensive and scalable portfolio built on the ARM® Cortex™-M4 core.
Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.
› Verified 2 days ago
| Provider Name | Alec R Pearlstein |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134268501 PECOS PAC ID: 8123211307 Enrollment ID: I20140728002641 |
News Archive
Research presented at the ASM Microbe research meeting provides compelling evidence that children acquire Streptococcus mutans, the bacterium most frequently associated with dental caries, from intra- and extra-familial sources besides their mother.
Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.
Freescale Semiconductor today announced the newest addition to its growing Kinetis 32-bit microcontroller (MCU) line - the Kinetis K50 family. This new family, targeted for medical and industrial applications, further expands the industry's most extensive and scalable portfolio built on the ARM® Cortex™-M4 core.
Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.
› Verified 2 days ago
News Archive
Research presented at the ASM Microbe research meeting provides compelling evidence that children acquire Streptococcus mutans, the bacterium most frequently associated with dental caries, from intra- and extra-familial sources besides their mother.
Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.
Freescale Semiconductor today announced the newest addition to its growing Kinetis 32-bit microcontroller (MCU) line - the Kinetis K50 family. This new family, targeted for medical and industrial applications, further expands the industry's most extensive and scalable portfolio built on the ARM® Cortex™-M4 core.
Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.
› Verified 2 days ago
Treatmedngo Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8950 W Olympic Blvd Ste 103&104, Beverly Hills, CA 90211 Phone: 310-274-8080 | |
Refael Medical, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8200 Wilshire Blvd, Beverly Hills, CA 90211 Phone: 310-879-7167 Fax: 310-933-5688 | |
Michael D. Borookhim, M.d., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9301 Wilshire Blvd, Suite 602, Beverly Hills, CA 90210 Phone: 310-288-0881 | |
Ultrasound Specialists Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9001 Wilshire Blvd, Suite 106, Beverly Hills, CA 90211 Phone: 310-273-8885 | |
Kaiser Permanente Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 S Arnaz Dr Apt 3, Beverly Hills, CA 90211 Phone: 213-215-5142 | |
Nancy P. Rahnama, M.d., A.p.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 421 N Rodeo Dr, Penthouse Number 1, Beverly Hills, CA 90210 Phone: 310-299-7373 Fax: 310-432-6647 | |
Laurence Seigler, M.d. Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 435 N Bedford Dr, Suite 308, Beverly Hills, CA 90210 Phone: 310-274-6158 Fax: 310-274-5709 |